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Basic transcription element binding protein (BTEB) is a member of the Krüppel family of zinc finger transcription
factors. It has been shown that BTEB plays a role in promoting neuronal process formation during post-
embryonic development. In the present study, the biochemical properties, transactivation function, and the




 (xBTEB) are described. xBTEB
binds the GC-rich basic transcription element (BTE) with high affinity and functions as a transcriptional activator
on promoters containing multiple or single GC boxes. xBTEB mRNA levels increase in the tadpole brain, intes-
tine and tail during metamorphosis, and are correlated with tissue-specific morphological and biochemical
transformations. xBTEB mRNA expression can be induced precociously in premetamorphic tadpole tissues by




 hybridization histochemistry showed that thyroid hormone upregulates
xBTEB mRNA throughout the brain of premetamorphic tadpoles, with the highest expression found in the sub-
ventricular zones of the telencephalon, diencephalon, optic tectum, cerebellum and spinal cord. xBTEB protein
parallels changes in its mRNA, and it was found that xBTEB is not expressed in mitotic cells in the developing
brain, but is expressed just distal to the proliferative zone, supporting the hypothesis that this protein plays a





















critical role in vertebrate development, particularly in
the maturation of the central nervous system (Legrand
1983; Porterfield & Hendrich 1993). However, the




 action in development remains





primary morphogen controlling metamorphosis. The
hormone acts by binding to nuclear receptors that
function as ligand-activated transcription factors, and
thus it activates tissue-specific gene regulation
programs. The protein products of these hormone-
inducible genes provide the basis for the dramatic
morphological and biochemical transformations that
are characteristic of metamorphosis. The immediate,
early gene regulation programs have been partially




. 1996), hindlimb (Buckbinder & Brown 1992),





1997). However, the biological functions of the protein
products of these genes have been characterized in
only a few cases (Shi 2000).
The basic transcription element binding protein





gene in gene expression screens of premetamorphic









. 1997). This gene is rapidly





these tissues. We showed that BTEB expression is














. 1992) in a
screen for proteins that bind to a GC-rich (GC box)
sequence in the promoter region of the cytochrome









DNA element was shown to be necessary for basal
transcription of P-450IA1 and it is required for maximal
inducible expression of this gene by xenobiotics; it





 1990). Subsequent to the initial
cloning of rat BTEB, other closely related genes were
identified in mammals. The rat BTEB gene first iso-




. (1992) is now designated
BTEB1, while two other paralogous members of this









. 2000). BTEB2 and BTEB3,
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however, are more distantly related to BTEB1 than
some of the other members of this family of transcrip-









) BTEB (xBTEB) shares greatest
sequence similarity with mammalian BTEB1 proteins
(Fig. 1).
The GC box sequence is commonly found in pro-
moters of cellular and viral genes, and was originally





1985; Courey & Tjian 1988; Mitchell & Tjian 1989).
BTEB proteins are members of the Krüppel-like family




. 2000). Krüppel is a protein



















fingers that form the DNA-binding domain (DBD) of
the protein. Krüppel-like proteins are distantly related
to Sp1 and other Sp family members, and share a high
degree of similarity in the DBD; for example, the DBD





. 1992). However, the proteins are
highly divergent outside of the DBD; for example, the
size of rat BTEB is 244 amino acids while rat Sp1 is
788 amino acids. Thus, one can predict that these
proteins present very different interfaces for protein–
protein interactions that govern which promoters are
regulated and the nature of the regulation.
In an effort to understand the role that BTEB plays
in amphibian metamorphosis and in vertebrate
development generally, we analyzed the molecular
and biochemical characteristics, and the expression





show that xBTEB binds DNA with high affinity and is
capable of activating transcription from GC box-
containing promoters. xBTEB mRNA is strongly upreg-




 in the brain, intestine and
tail, and shows a developmental pattern of expression
that parallels the morphological and biochemical
transformations that occur in each tissue. In addition,
we verified that xBTEB protein is expressed during





is not expressed at detectable levels in cells induced




 treatment, but is strongly upregu-
lated in adjacent cells. This finding supports previous
findings in mammalian cells which show that BTEB

















 tadpoles were raised in dechlorinated





pulverized rabbit chow ad libitum. Developmental
stages were assigned according to the Nieuwkoop





acid sequences for mammalian
basic transcription element





The DNA-binding domain of









 zinc fingers (residues 145–
167, 175–197 and 205–227 of rat,
and residues 193–215, 223–245
and 253–275 of frog), is highly
conserved between mammals
and amphibians. Similarly, the
putative transcriptional activation
domains are highly conserved
(region A, residues 13–26 of both
rat and frog; region B, residues
33–50 of rat and residues 88–98
of frog). GenBank accession
numbers for amino acid sequ-







(AAC59863) and 1B (AAC59864).
Red bars indicate the putative
transactivation domains (A and B)
and purple bars designate the
three zinc fingers (1, 2 and 3; DNA-binding domain). Four putative phosphorylation sites are designated ‘P’. Black shading indicates














































Thyroid hormones or drugs were administered by
addition to the aquarium water; water was changed
and drugs or hormones replenished daily over the




(sodium salt; Sigma-Aldrich, St Louis, MO, USA) at 5,













; Sigma-Aldrich) for 10 days.
The goitrogen methimazole (MMI; Sigma-Aldrich) was













tration was determined by radioimmunoassay (RIA;
Mackenzie & Licht 1984; Denver & Licht 1988).




 was purchased from Dr
Viggo Kruse (Denmark). All samples were measured










 BTEBa gene (GenBank accession no.
U35408) was isolated by polymerase chain reaction










 BTEBa but not BTEBb



















. A region containing the DBD of
xBTEB (amino acid residues 120–292) was PCR
amplified with the full-length xBTEB cDNA as template









) and the same reverse
primer as above. The cDNAs for the full-length xBTEB













I restriction sites. The pGEX-KG
prokaryotic expression vector (Guan & Dixon 1991)
was used to express xBTEB and xBTEB[DBD] as
fusion proteins with a glutathione-S-transferase
(GST) tag. Both cDNAs were also subcloned into
the pCMV-Neo eukaryotic expression vector (a gift of
Michael Uhler, The University of Michigan, Ann









produce pCMV-xBTEB and pCMV-xBTEB[DBD]. The
constructs were verified by DNA sequencing using
the Rhodamine dye terminator cycle sequencing kit
(PE Applied Biosystems, Foster City, CA, USA).
 
Recombinant fusion protein expression and 
purification







 transformed with either pGEX-















Cells were harvested by centrifugation and then they





























 (pH 7.3) and 1% Triton X-100 (PBST).
The cell lysate was isolated by brief sonication on ice









To determine the solubility of each fusion protein,
fractions of the lysate and insoluble pellet (containing
inclusion bodies) were analyzed by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE). The GST-xBTEB[DBD] was present in the
lysate fraction and was isolated under non-denaturing
conditions. However, GST-xBTEB was insoluble and
required denaturing conditions for purification.
 
Purification of fusion proteins
 
The soluble GST-
xBTEB[DBD] fusion protein was purified as described
by Guan & Dixon (1991) using a 50% (v/v) slurry of
glutathione-agarose beads (Sigma-Aldrich). Insoluble
GST-xBTEB was purified from bacterial inclusion
bodies under denaturing conditions. The pellet was









10 min, fractionated by 10% SDS–PAGE, and fusion
protein recovered from gel slices by electroelution.
After dialysis to remove SDS, aliquots of both purified
recombinant proteins were analyzed by SDS–PAGE to
estimate protein purity and concentration (with bovine
serum albumin [BSA] standards).
 
Antibody production and affinity purification
 
A polyclonal antiserum was generated in rabbit
against GST-xBTEB by a commercial laboratory
(Lampire Biological Laboratories, Pipersville, PA,
USA). The immunoglobulin (IgG) fraction of the anti-
xBTEB serum (2 mL) was purified by affinity chroma-
tography on an Affi-Gel protein A column (Bio-Rad
Laboratories, Hercules, CA, USA) according to the
manufacturer’s protocol. This fraction was further
purified by affinity column chromatography using a
GST-xBTEB[DBD] affinity column. For affinity column
purification, the Affi-Gel 10 support (Bio-Rad Labora-
tories) was chosen based on the isoelectric point of
the GST-xBTEB[DBD] (pI = 9.12; calculated using
Vector NTI software; Informax, Bethesda, MD, USA).
The affinity column was prepared following the
manufacturer’s protocol by coupling 2 mg GST-
xBTEB[DBD] to 1 mL washed support. The column
flow-through, which contained antibodies to the
N-terminal region of xBTEB, was collected and
re-applied to the affinity column twice (i.e. antibodies
to the DBD of xBTEB and the GST were ‘subtracted’).
The specificity of the resultant affinity subtracted IgG
 




was verified by western blotting. The purified IgG
reacted strongly with the full-length xBTEB fusion
protein but did not recognize GST-xBTEB[DBD] or
GST alone (data not shown).
 
Electrophoretic mobility shift assay
 
Electrophoretic mobility shift assay (EMSA) analyses




. (1998), with minor modifications. The BTE and





. (1990). Recombinant proteins









T system; Promega, Madison, WI, USA;




























g total cellular protein) were incubated in a




L with 20 000–60 000 c.p.m. 
 
32P-BTE
and 1.4 µg double-stranded poly(dI-dC) in a buffer
containing 20 mM HEPES (pH 7.8), 1 mM dithiothreitol
(DTT), 0.1% IGEPAL CA-630 (Sigma-Aldrich), 50 mM
KCl and 20% glycerol. Unlabeled BTE or mBTE were
added as specific or non-specific competitors,
respectively. The reaction continued at room temper-
ature for 40 min before fractionation by 6% non-
denaturing PAGE. The gel was dried and analyzed by
autoradiography. For antibody supershifts, 5 µL of
straight (unpurified) anti-xBTEB, antirat BTEB (a gift of
Dr Fujii-Kuriyama, Tohuku University, Sendai, Japan),
normal rabbit serum (NRS) or 1 µL antihuman Sp1
serum (Geneka Biotechnology, Montreal, Québec,
Canada) was added to the EMSA reaction and
incubated at room temperature for 20 min before
adding the probe.
The DNA-binding affinities of the bacterially
expressed GST-xBTEB and GST-xBTEB[DBD] were
determined by EMSA competitive binding assays
using cold BTE (or mBTE) as competitor, 32P-BTE as
probe and 0.5 ng purified fusion protein (which gave
approximately 50% binding in the assay; mBTE did
not compete for binding in this assay; data not
shown). The resulting autoradiographs were digitized
using a flatbed scanner and the mean density of the
supershifted bands was measured using Scion Image
software (version 3.0; Scion Corporation, Frederick,
MD, USA). An inhibition constant (Ki) for each assay
was calculated by fitting data to the following
regression equation using the computer program
Sigmaplot (version 5.0; SPSS Science, Chicago, IL,
USA): y = 1 – (ax) / (b + x) (Cortright et al. 1995),
where y is the relative intensity of the band as
determined by optical density; x is the molar concen-
tration of competitor; a is the intensity of the band in
the absence of competitor; and b is the Ki. A mean Ki
was calculated from data from three independent
binding assays for each protein.
Cell culture and transient transfections
Cells were cultured in a humidified atmosphere of 5%
CO2. The incubation temperature was 37C for mam-
malian and 25C for amphibian cells. CV-1 cells were
cultured in Dulbecco’s modified Eagle’s medium
(DMEM; Sigma-Aldrich) and XTC-2 cells in Leibovitz-
15 medium (L-15; Invitrogen Life Technologies,
Carlsbad, CA, USA; diluted 1:1.5 for amphibian
cells). All growth media were supplemented with
sodium bicarbonate (2.47 g/L), penicillin G sodium
(100 U/mL), streptomycin sulfate (100 µg/mL) and
10% fetal bovine serum. Chloramphenicol acetyl
transferase (CAT) content in cell extracts at the end of
experiments was analyzed using a CAT-ELISA kit
following the manufacturer’s instructions (Roche,
Mannheim, Germany). Total cellular protein was
analyzed by the Bradford method (Pierce, Rockford,
IL, USA) and CAT content was normalized to protein
content.
Transfection of XTC-2 cells XTC-2 cells were plated
at a density of 5  105 per 6 cm dish, 24 h before
transfection. The polyethylenimine (pEi) method
(Meunier-Durmort et al. 1997) was used for transient
transfection. The total amount of DNA was kept
constant by adding pCMV-Neo (empty vector) as a
carrier. Cells were washed twice with serum-free L-15,
and the pEi/DNA in L-15 was added directly to the
cells. After 1 h of incubation, the transfection medium
was replaced with growth medium. Cells were
incubated for 24 h before harvesting and extraction
for EMSA analyses (Ranjan et al. 1994).
For reporter assays in XTC-2 cells, cells were
co-transfected with a X. laevis thyroid receptor 
promoter-CAT plasmid (xTR/CAT; generously pro-
vided by Dr J. R. Tata, National Institute of Medical
Research, London, UK; Machuca et al. 1995) and
varying concentrations of pCMV-xBTEB[DBD]. Cells
were incubated in the absence or presence of 30 nM
T3 for 24 h before harvesting and analysis of CAT
expression (this dose of T3 produced near maximal
induction in a previous experiment; E. D. Hoopfer and
R. J. Denver, unpubl. data, 2000). In a separate
experiment, plates were harvested for analysis of BTE
binding activity by EMSA.
Transfection of CV-1 cells Transient transfection of
CV–1 cells by the calcium phosphate precipitation
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method (Gorman et al. 1982) was carried out under
the same conditions used by Imataka et al. (1992)
for analysis of rat BTEB and Sp1. Cells were co-
transfected with 3 µg promoter/reporter plasmids and
15 µg of expression plasmids. Promoter/reporter
plasmids used were pSV2CAT (Gorman et al. 1982),
pSV/MC53 (Yanagida et al. 1990) or pSV/MC53 +
4GC (Imataka et al. 1992). pSV2CAT contains the
simian virus 40 (SV40) early promoter driving expres-
sion of CAT (this native promoter has six GC boxes;
Gorman et al. 1982). pSV/MC53 (Yanagida et al.
1990) and pSV/MC53 + 4GC (Imataka et al. 1992)
contain a single GC box and five GC boxes, respec-
tively, inserted between the SV40 enhancer and TATA
box driving CAT. Expression plasmids used were
pCMV-Neo (empty vector), pCMV-xBTEB, pRSV-
rBTEB or pRSV-rSp1 (Imataka et al. 1992). Following
transfection, cells were incubated for 24 h before
harvesting for analysis of CAT expression. Each trans-
fection experiment was repeated three times.
RNA isolation and northern blot analysis
RNA was isolated from individual adult brains (dien-
cephalon) and pooled tadpole brains (diencephalon,
10 per pool; intestine, three per pool; and tail, three
per pool) using Trizol reagent (Gibco BRL). Northern
blots were prepared with 10 µg total RNA as
described by Denver et al. (1997). Blots were probed
with a 32P-labeled xBTEB cDNA generated by
random priming (Amersham Pharmacia Biotech,
Piscataway, NJ, USA). The same blots were stripped
and reprobed with a 32P-labeled cDNA for the
X. laevis ribosomal protein L8 gene (rpL8; Shi & Liang
1994) to normalize for RNA loading. Each experiment
analyzing xBTEB mRNA expression was replicated
three times. Blots were digitized and the mean density
of the bands was determined using Scion Image
software.
Histochemistry
Animal treatment and tissue preparation  Premeta-
morphic (NF stage 52–54) or late prometamorphic (NF
stage 60) tadpoles were treated with or without 50 nM
T3 for 48 h before they were killed and tissue was
harvested. To analyze cell proliferation in the brain,
tadpoles treated with or without T3 were cultured in
500 µM bromodeoxyuridine (BrdU; Sigma-Aldrich) 3 h
before they were killed. Whole heads (premeta-
morphic) or brains (prometamorphic) were removed
and fixed in 4% paraformaldehyde for 24 h at 4C and
then were saturated in 30% sucrose for 24 h. Tissues
were embedded in OCT compound (Sakura [Tissue-
Tek], Torrence, CA, USA), frozen, and cryosectioned
saggitally at 20 µm. Five brains per treatment or
developmental stage were used for each histo-
chemical analysis.
In situ hybridization histochemistry for xBTEB mRNA
In situ hybridization histochemistry (ISSH) for xBTEB
mRNA was conducted following methods described
by Mansour et al. (1994). Linearized pBluescript-
xBTEB plasmid templates were prepared and full-
length sense or antisense digoxigenin (DIG)-labeled
xBTEB cRNA probes were transcribed in vitro using a
DIG RNA labeling kit (Roche). Cryosections were
hybridized overnight at 42C with 1 µg probe per
100 µL hybridization buffer (Hybrisol; Intergen,
Norcross, GA, USA). RNA hybrids were revealed
using a monoclonal mouse anti-DIG IgG following
the manufacturer’s protocol (Roche) and fluorescent
immunodetection was achieved using a goat anti-
mouse secondary antibody conjugated with either
fluorescein isothiocyanate (FITC) or Cy3 (1:500;
Jackson Immunoresearch Laboratories, West Grove,
PA, USA). Slides were coverslipped with Prolong
(Molecular Probes, Eugene, OR, USA) before
confocal microscopy.
Combined in situ hybridization histochemistry for
xBTEB mRNA and immunohistochemistry for thyroid
hormone receptors Double-labeling fluorescent
immunohistochemistry (IHC) was used to detect
thyroid hormone receptor (TR) protein and xBTEB
mRNA on the same brain section. Slides were first
processed for ISHH for xBTEB mRNA as described
above followed by simultaneous immunodetection of
the xBTEB DIG-cRNA probe and TR protein. The
rabbit anti-X. laevis TR polyclonal serum used was a
gift of Dr Yun-Bo Shi (National Institutes of Health,
Bethesda, MD, USA). This antiserum was raised
against a multiple antigenic peptide corresponding to
amino acids 104–123 of X. laevis TR. In western
blotting experiments using in vitro synthesized
X. laevis TR or TR proteins, we discovered that this
antiserum recognizes both receptor subtypes (data
not shown). Therefore, our experiments do not
distinguish TR from TR but rather provide a
composite measure of total TR protein.
Cryosections of tadpole brain were incubated with
anti-X. laevis TR serum (1:1000) for 24 h at 4C. The
secondary antibody used was a goat-antirabbit-FITC.
Positive staining of xBTEB mRNA and/or TR protein
was analyzed with a Zeiss laser scanning confocal
microscope (Carl Zeiss, Thornwood, NY, USA).
Sections were scanned at 1 µm using Z-stack to
determine if xBTEB mRNA and TR protein were in the
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same focal plane, thus ruling out the possibility of
false co-localization.
Immunohistochemistry for xBTEB protein and
bromodeoxyuridine xBTEB protein was detected
by IHC using the affinity-purified anti-xBTEB IgG
described above. Cryosections of tadpole brain were
prepared and incubated with the purified anti-xBTEB
IgG (1:100). Two different secondary antibodies were
used: for fluorescence we used an antirabbit-Cy3
(1:500; Jackson Immunoresearch) and for enzymatic
detection (with diaminobenzidine) we used a biotiny-
lated antirabbit IgG (ABC kit; Vector Laboratories,
Burlingame, CA, USA) To verify the specificity of the
anti-xBTEB IgG we preabsorbed the antiserum with
recombinant GST-xBTEB fusion protein (1 µg/mL) at
4C overnight before application to adjacent tissue
sections.
For double-labeling IHC, tadpole brain sections
were first processed for detection of BrdU followed by
IHC for xBTEB protein. Briefly, tissue sections were
denatured with 2 N HCl at 37C for 30 min, rinsed,
and blocked with 5% normal goat serum (NGS) at
room temperature for 15 min. Tissue sections were
then incubated with anti-BrdU serum (1:500; gener-
ated in rat; Serotec, Raleigh, NC, USA) for 24 h at
room temperature. Antirat-FITC allowed fluorescent
detection of primary anti-BrdU immune complexes.
For subsequent detection of xBTEB protein, sections
were incubated with anti-xBTEB IgG as described
above, and immune complexes were detected using
an antirabbit-Cy3 secondary antibody.
Data analysis and statistics
Data were analyzed by Student’s unpaired t-test or
one-way ANOVA using the Systat (version 7.0; SPSS
Science) computer program. For ANOVA, data were
log-transformed before analysis if the variances were
found to be heterogeneous. Scheffe’s posthoc test
allowed separation of means. P < 0.05 was taken as
the limit for significance.
Results
Structural comparison of mammalian BTEB1 and 
X. laevis BTEB proteins
Because X. laevis is pseudotetraploid, it possesses
two BTEB genes (designated BTEBa and BTEBb;
Brown et al. 1996). The two frog proteins show
greatest similarity in primary structure to the mam-
malian BTEB1 proteins (Fig. 1). Amino acid sequence
alignment of the mammalian BTEB1 and the two
X. laevis BTEB proteins shows that they share several
highly conserved regions for which biochemical
functions (for the mammalian proteins) have been
identified (Fig. 1). Frog BTEBa and rat BTEB1 (292
and 244 amino acids, respectively) share 99% simil-
arity in their DBD, characterized by three Cys2–His2
zinc fingers.
Less conserved between mammals and frogs are
the N-terminal domains, where deletions and/or
insertions, in addition to amino acid substitutions,
have occurred during evolution. Mutational analysis
identified two functional domains in the rat BTEB1
protein that function in transcriptional activation
(region A, residues 13–26 and region B, residues
58–68; Fig. 1; Kobayashi et al. 1995). Both of these
transactivation domains are largely conserved in the
frog BTEB proteins. A sequence of four amino acids
(Leu–Val–Ser/Thr–Ile) present in both domain A and B
of rat BTEB1 (Kobayashi et al. 1995) are entirely
conserved in the corresponding regions of the frog
proteins (Fig. 1).
For biochemical analysis we focused on X. laevis
BTEBa. There are four amino acid differences
between frog BTEBa and BTEBb, and two substi-
tutions occur within the DBD. One substitution falls
within the first zinc finger, and while the mammalian
BTEB1 and the frog BTEBb proteins have a tyrosine
at this position, frog BTEBa has a phenylalanine.
However, given that the frog BTEBa and mammalian
BTEB1 proteins possess similar DNA-binding proper-
ties and transactivational activities, we think that it is
unlikely that the two frog proteins differ in their func-
tional properties. Our RNA or protein analyses did not
distinguish the two gene products. Here we use the
abbreviation xBTEB to refer to frog BTEB proteins,
without distinguishing BTEBa or b.
Biochemical analysis of xBTEB
Expression of xBTEB in vitro resulted in a band on
reducing SDS–PAGE with an apparent molecular
mass of approximately 32 kDa: the molecular mass
predicted from the nucleotide sequence is 32.8 kDa.
The identity of this protein was verified by western
blotting using antixBTEB serum, and the protein was
not present in unprogrammed or empty vector
programmed lysate (data not shown). Further reso-
lution of the in vitro expressed xBTEB on reducing
12.5% SDS–PAGE revealed that the band consisted of
a doublet (Fig. 2a; both proteins reacted with the
anti-xBTEB serum, data not shown). This protein
heterogeneity could result from run-on transcription in
the in vitro system, or from post-translational modifi-
cation.
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The in vitro expressed xBTEB was tested for its
ability to bind the BTE by EMSA. In vitro expressed
xBTEB formed two supershifted bands (Fig. 2b), and
these bands were further supershifted with anti-xBTEB
and anti-rBTEB serum, but not with normal rabbit
serum (NRS), showing that both protein–DNA
complexes contained xBTEB (no supershifted bands
were observed with unprogrammed or empty vector
programmed lysate; data not shown.)
To determine if the two protein–DNA complexes
observed by EMSA were an artifact of expressing
xBTEB in vitro, we overexpressed xBTEB by transient
transfection of XTC-2 cells. For comparison, we also
overexpressed rat BTEB1. As with the in vitro
expressed xBTEB, two protein–DNA complexes were
observed by EMSA in extracts from xBTEB-over-
expressing cells (Fig. 2c); these complexes were not
observed in untransfected or empty vector trans-
fected cell extracts (data not shown). The low mobility
complex is tentatively designated frog Sp1 based on
its high molecular mass and the ability of antihuman
Sp1 serum to supershift it; Sp1 was present in trans-
fected, untransfected or empty vector transfected cell
extracts (data not shown). Both protein–DNA com-
plexes obtained by overexpressing xBTEB could be
supershifted with anti-xBTEB serum, but not with NRS,
supporting the conclusion that both complexes
contained xBTEB (Fig. 2c). By contrast, a single
protein–DNA complex was observed in cell extracts of
rBTEB-overexpressing cells that could be super-
shifted by antirat BTEB1 serum (Fig. 2c).
Thus, with two different expression constructs in two
different expression systems, we observed hetero-
geneity with frog BTEB protein–DNA complexes. We
have not examined the basis for this protein hetero-
geneity, but it is possible that it could result from post-
translational modification. For example, xBTEB has
several unique phosphorylation sites (Fig. 1) that
could generate proteins of varying molecular masses.
Note that these putative phosphorylation sites are
present in non-conserved regions of the frog protein
(Fig. 1) and this could explain the lack of hetero-
geneity in the rat BTEB1.
Competitive binding assays using E. coli expressed
GST-xBTEB or GST-xBTEB[DBD] showed that both
proteins had relatively high and similar affinities for
32P-BTE, with a mean Ki of 17 nM ± 5.4 nM for GST-
xBTEB and 23 nM ± 2.3 nM for GST-xBTEB[DBD]
(n = 3).
xBTEB activates transcription from GC 
box-containing promoters
We next tested the ability of xBTEB expressed in
mammalian cells to transactivate the SV40 early
promoter, a naturally occurring viral promoter con-
taining six contiguous GC box sequences (pSV2CAT).
For the transient transfection assays, we followed the
Fig. 2. Biochemical characteriz-
ation of Xenopus laevis basic tran-
scription element binding protein
(BTEB). (a) Flourogram of in vitro
expressed Xenopus BTEB (xBTEB)
protein resolved by sodium
dodecylsulfate–polyacrylamide gel
electrophoresis (SDS–PAGE). The
apparent molecular mass of xBTEB
is 32 kDa, as predicted from the
nucleotide sequence. (b) Electro-
phoretic mobility shift assay (EM-
SA) of in vitro produced xBTEB
protein with labeled basic tran-
scription element (BTE) probe and
supershifted with either anti-
X. laevis or anti-rat BTEB serum
(lanes 2 and 3, respectively; Ab,
bands supershifted by antisera) or
normal rabbit serum (NRS; lane 4).
No supershifted bands were
observed with unprogrammed or
empty vector programmed lysate; data not shown. (c) Overexpression of X. laevis and rat BTEB in XTC-2 cells. EMSA analysis of
lysate from XTC-2 cells transiently transfected with either X. laevis or rat BTEB expression vector. Labeled BTE was used as the probe,
and either antixBTEB, antiratBTEB or NRS (lanes 2, 3 and 5, respectively) was added to the reaction (indicated below the gel). Arrows
show BTEB protein–DNA complexes, BTE supershifted by endogenous Sp1 protein or antibody-supershifted complexes (Ab). These
BTEB protein–DNA complexes were not observed in untransfected or empty vector transfected cell extracts (data not shown).
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methods, and used the reporter and expression
plasmids developed by Imataka et al. (1992) to
compare results between laboratories. Cotransfection
with pCMV-xBTEB produced a statistically significant
(P < 0.01; t-test) elevation in CAT expression driven by
the SV40 promoter (pSVCAT), inducing a 3.4-fold
increase over empty vector transfected controls
(Fig. 3a). The rat BTEB1 or rat Sp1 expression vectors
also produced statistically significant increases in
CAT expression over controls (2.3-fold and twofold,
respectively; P < 0.05 for each; t-test; Fig. 3a). We
also found that xBTEB activated transcription from the
synthetic pSV/MC53 + 4GC promoter, which contains
five contiguous GC boxes (data not shown).
Imataka et al. (1992) reported that CAT expression
driven by the synthetic pSV/MC53 promoter (contain-
ing a single GC box sequence), was inhibited by rat
BTEB but activated by rat Sp1. We therefore
compared rat BTEB1 and xBTEB in co-transfection
experiments with pSV/MC53. By contrast with the
findings of Imataka and colleagues, in our hands
both rat BTEB1 and xBTEB significantly activated
transcription by pSV/MC53 (P < 0.01 and P < 0.05,
respectively; t-test), and we found no evidence for
transcriptional repression by either protein (Fig. 3b).
Although equal quantities of DNA were used for
each expression vector, we did not quantify the
amount of protein expressed and so cannot make
quantitative comparisons of the transactivational
potencies of each protein. Because of the difficulties
of conducting transfection efficiency controls (i.e.
most promoters employed to express indicator
proteins contain GC box sequences in their pro-
moters and thus would not be appropriate to use
as transfection controls; Imataka et al. 1992) we
repeated our transfection experiments three times
with different batches of plasmid DNA to verify the
reproducibility of our experiments.
xBTEB[DBD] represses basal and hormone-
induced transcription from the X. laevis TR 
promoter
We tested whether xBTEB[DBD] could inhibit, in a
dominant negative fashion, transcription from the
X. laevis TR promoter (Machuca et al. 1995) which
contains seven GC boxes and is autoinduced during
metamorphosis (Tata et al. 1993). XTC-2 cells express
TR, and the TR gene can be autoinduced by the
addition of T3 to the cell culture (Machuca & Tata
1992). Expression of xBTEB[DBD] in XTC-2 cells
resulted in a dose-dependent competition for endo-
genous BTE-binding activity (Fig. 4a). Addition of T3
(30 nM) induced a greater than 18-fold increase in CAT
expression driven by the xTR-promoter (Fig. 4b).
Overexpression of xBTEB[DBD] reduced, in a dose-
dependent manner, both basal and T3-induced CAT
expression (Fig. 4b). Basal CAT expression was
Fig. 3. Xenopus laevis basic transcription element binding
protein (BTEB) activates transcription from promoters containing
single or multiple GC boxes. CV1 cells were transfected as
described in the Materials and Methods and cultured for 24 h
before harvesting for analysis of chloramphenicol acetyl
transferase (CAT) expression. CAT content was normalized to
total cellular protein, and the data are expressed as fold change
relative to the control (empty expression vector transfected
cells = 1). (a) CV-1 cells were co-transfected with the desig-
nated expression vectors plus the pSV2CAT promoter/reporter
plasmid (this native promoter contains six contiguous GC box
sequences.) The data in the graph represent the mean (± SEM)
of three separate transfection experiments. (b) CV-1 cells were
co-transfected with the designated expression vectors and
promoter/reporter vectors. The pSV/MC53 vector drives CAT
expression and contains the SV40 enhancer and a single GC
box sequence. The data in the graph represent the mean
(± SEM) of three replicates in one transfection experiment.
Asterisks in both upper and lower panels designate significant
differences from the controls (*, P < 0.05; **, P < 0.01 by
Student’s unpaired t-test).
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reduced to less than 50% of control levels by trans-
fection with 1 µg pCMV-xBTEB[DBD], while trans-
fection with 10 µg of this expression vector rendered
basal CAT expression undetectable. Similarly, T3-
induced CAT expression was reduced to 79 and 39%
of controls by transfection with 1 and 10 µg, respec-
tively, pCMV-xBTEB[DBD].
Developmental and hormone-dependent 
expression of xBTEB mRNA
Northern blotting showed the presence of three
xBTEB transcripts (1, 4 and 10 kb) in the tadpole brain,
intestine and tail (Fig. 5); however, we did not observe
differential regulation of the individual transcripts at
any stage of development in the three tissues
analyzed. xBTEB mRNA expression in the brain and
intestine was low during premetamorphosis and early
prometamorphosis, but rose during prometamor-
phosis to reach a peak at metamorphic climax (NF
stage 60–62). Expression then declined to low levels
in the juvenile frog. xBTEB mRNA expression in the tail
was low throughout metamorphosis but rose sharply
during metamorphic climax, with highest levels at NF
stage 64, when the tail undergoes rapid resorption.
Treatment of premetamorphic tadpoles (NF stage
52) with T3 (5 or 50 nM) produced a dramatic upregu-
lation of xBTEB mRNA in brain and intestine (Fig. 6;
only data for the 50 nM dose are shown). T3-induced
upregulation of xBTEB mRNA was observed by 4–8 h
after addition of the hormone and was maximal in both
brain and intestine by 12–16 h: xBTEB mRNA expres-
sion remained elevated throughout the entire 72 h of
exposure to T3. xBTEB mRNA expression in the tail
was not altered by the addition of 5 or 50 nM T3 (data
not shown). In separate experiments, addition of T3 to
the aquarium water to a concentration of 200 nM
resulted in a dramatic increase in xBTEB mRNA in the
tail by 12 h (earlier time points were not analyzed) and
expression remained high throughout the 48 h of
exposure to the hormone (a representative northern
blot is shown in Fig. 6c).
To determine if the elevated expression of xBTEB
mRNA during prometamorphosis depends on endo-
genous T3, NF stage 58 tadpoles were treated with or
without the goitrogen MMI (1 mM) dissolved in the
aquarium water for 7 days. Over this time-frame, the
average developmental stage of the animals at the
end of the experiment was not significantly different
between control and MMI-treated tadpoles (data not
shown). MMI-induced hypothyroidism reduced the
expression of xBTEB mRNA compared to untreated
control animals (Fig. 6d).
Several genes that show T3-dependent regulation in
fetal/neonatal brain of mammalian species, including
BTEB1 (Denver et al. 1997), become thyroid inde-
pendent later in life (at 30 days postnatally in rodents;
Oppenheimer & Schwartz 1997). We tested whether
thyroid hormone could regulate xBTEB mRNA levels
in the adult X. laevis brain. Adult male frogs were
treated with 20 nM T4, 1 mM MMI or MMI + T4 for
2 weeks by adding the hormone or drug to the rearing
water. Plasma T4 was analyzed by RIA to verify the
effectiveness of the treatments (note that T3 is low to
non-detectable in adult frog plasma; thus, we treated
with and measured T4 to allow verification of both
hypothyroid and hyperthyroid states). A hyperthyroid
state was induced by exposure to 20 nM T4 (plasma
T4: 5.24 ± 2.05 vs 0.48 ± 0.16 ng/mL in controls)
Fig. 4. Dominant negative activity of xBTEB[DBD] on the xTR
promoter in Xenopus laevis XTC-2 cells. XTC-2 cells were trans-
fected with 1 µg xTR-promoter-CAT and varying amounts of
pCMV-xBTEB[DBD] as described in the Materials and Methods.
Cell extracts were analyzed for (a) basic transcription element
(BTE)-binding activity by electrophoretic mobility shift assay
(EMSA; P, probe only) or (b) for chloramphenicol acetyl trans-
ferase (CAT) expression by CAT ELISA. In (b), cells were treated
with or without 30 nM 3,5,3-triiodothyronine (T3) for 24 h before
harvest. Means of three replicates with SEM are given.
374 E. D. Hoopfer et al.
and a hypothyroid state by exposure to MMI (non-
detectable plasma T4). Treatment with MMI + T4
restored plasma T4 concentrations to approximately
twice the control value (0.98 ± 0.1 ng/mL); however,
plasma T4 concentrations in the T4 + MMI group were
well below those in the T4 alone group. MMI is an
inhibitor of thyroid peroxidase and thus acts to block
the organification of iodide within the thyroid gland
(Taurog 1996). We currently cannot explain why T4
replacement was ineffective in the MMI treated frogs,
but our findings may point to an extrathyroidal action
of this goitrogen in frogs which serves to alter thyroid
hormone metabolism/excretion.
xBTEB mRNA levels in the brain were significantly
increased by exposure to T4 (approximately 30%
above controls; F(3,17) = 48.7, P < 0.0001; ANOVA; data
not shown). The xBTEB mRNA level was not altered by
MMI treatment. However, the level of xBTEB mRNA
expression in controls was low, and thus we were
unable to quantify decreases from this already low
level of expression by northern blotting. xBTEB mRNA
levels in the T4 + MMI group were not different from
controls.
Distribution of xBTEB mRNA and regulation by T3 in 
the tadpole brain
In situ hybridization histochemical analysis of xBTEB
mRNA expression was conducted on brains obtained
from premetamorphic tadpoles (NF stage 52) treated
with or without T3 (50 nM) for 48 h. Hybridization with
the sense cRNA xBTEB probe gave no hybridization
signal (data not shown). The specificity of the anti-
sense xBTEB cRNA probe is further demonstrated by
the dramatically increased signal following exposure
to T3 (Fig. 7, compare panel A vs B [green] or panel C
vs D [red]). Treatment with exogenous T3 resulted in a
dramatic increase in xBTEB mRNA expression in
several brain areas (an example of this induced
expression is given for the optic tectum and the lateral
motor column in Fig. 7B and D, respectively). Areas of
highest xBTEB mRNA expression were observed in
the telencephalon, diencephalon, optic tectum, cere-
bellum and spinal cord (the neural retina and the
olfactory bulbs were not included in the analysis). In
all brain regions, xBTEB mRNA expression was
observed in the subventricular zones, just outside of
Fig. 5. Expression of the Xenopus
basic transcription element binding
protein (xBTEB) mRNA in the brain
(diencephalon), intestine and tail
during tadpole metamorphosis.
Tissues were collected from
Xenopus laevis tadpoles at different
developmental stages and ana-
lyzed by northern blot. Represen-
tative northern blots of the
developmental expression of xBTEB
mRNA in the tadpole (a) dience-
phalon, (b) intestine and (c) tail.
Graphs show the densitometric
quantitation of northern blot data
(n = 3 per tissue). Bars in the graph
represent the mean mRNA level,
expressed as a percentage of
maximal expression.
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the proliferative zones (zones of proliferation were
identified by BrdU labeling or by IHC for phospho-
histone 3 expression; L. Huang and R. J. Denver,
unpubl. data, 2001). An example of xBTEB mRNA
expression in the subventricular zone and in deep
cellular layers of the tectum is shown in Fig. 7B.
xBTEB mRNA co-localizes with thyroid hormone 
receptor protein
Combined histochemical analysis showed that xBTEB
mRNA and TR protein are co-localized in cells that
upregulate xBTEB mRNA (an example from the motor
column is given in Fig. 7C,D). Both xBTEB mRNA and
TR protein are strongly upregulated by 48 h T3 treat-
ment. The xBTEB mRNA signal is exclusively cyto-
plasmic while the TR protein is nuclear, as expected.
Note the dramatic increase in xBTEB mRNA expres-
sion (red) and the detection of TR protein (green
towards the center of the nuclei and yellow near the
nuclear envelope owing to the merge) following T3
treatment. The TR immunoreactivity, while restricted to
cell nuclei, occurred in a punctate pattern, with the
majority of the immunoreactive material located at the
periphery of the nucleus.
Distribution of xBTEB immunoreactivity in the late 
prometamorphic tadpole brain
We conducted IHC using the affinity subtracted anti-
xBTEB IgG to analyze xBTEB protein expression in the
late prometamorphic tadpole brain (when xBTEB
mRNA expression is high; based on northern blotting
analysis). We confirmed the specificity of the histo-
chemical reaction by conducting preabsorbtion
studies with recombinant xBTEB protein (data not
shown). In the late prometamorphic/early climax stage
tadpole brain (NF stage 60) xBTEB immunoreactivity
was strong and restricted to cell nuclei. xBTEB
immunoreactivity was observed in the telencephalon,
optic tectum, diencephalon, cerebellum and spinal
cord, corresponding to brain regions that showed
xBTEB mRNA expression. The highest xBTEB
immunoreactivity was observed in the hypothalamus
and the lateral motor column (data not shown).
Developmental and hormonal regulation of xBTEB 
immunoreactivity in the tadpole brain
Treatment of premetamorphic tadpoles with T3
resulted in a dramatic increase in xBTEB immuno-
Fig. 6. 3,5,3-triiodothyronine (T3)
upregulates Xenopus basic tran-
scription element binding protein
(xBTEB) mRNA in the brain
(diencephalon), intestine and tail of
premetamorphic Xenopus laevis
tadpoles. Stage 52 X. laevis
tadpoles were treated with either
50 nM (for brain and intestine blots)
or 200 nM T3 (for tail blot) in the
aquarium water and tissues were
collected at various times there-
after and analyzed by northern
blot. Representative northern blots
of xBTEB mRNA expression in the
(a) diencephalon, (b) intestine and
(c) tail, respectively. Graphs show
the densitometric quantitation of
northern blot data (n = 3 per
tissue). Bars in the graphs repre-
sent the mean mRNA level, expres-
sed as a percentage of maximal
expression (n = 3 blots per tissue).
(d) xBTEB gene expression during
metamorphosis depends on
thyroid hormone. Northern blot of
xBTEB mRNA expression in the
diencephalon of prometamorphic
(Nieuwkoop and Faber stage 58)
X. laevis tadpoles treated with the
goitrogen methimazole (1 mM) for
7 days.
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reactivity in the same brain regions that had shown
enhanced xBTEB mRNA with T3 (Fig. 8; shown for the
optic tectum and the cerebellum). xBTEB immuno-
reactivity increased during metamorphosis and was
high in the late prometamorphic tadpole brain (Fig. 8).
Exposure to exogenous T3 failed to alter xBTEB
immunoreactivity in late premetamorphic tadpoles,
probably owing to the maximal level of xBTEB expres-
sion at this later developmental stage.
xBTEB immunoreactivity is excluded from 
proliferative cells in the tadpole brain
Thyroid hormone induces proliferation in the tadpole
brain (Weiss & Rossetti 1951; Chibon & Dournon
1974). To test whether xBTEB protein is expressed in
brain cells undergoing mitosis, we conducted dual
labeling IHC for xBTEB and BrdU. T3 treatment
caused a robust increase in the number of BrdU-
positive cells in the periventricular zone of the optic
tectum (Fig. 8). Combined histochemistry for BrdU
and xBTEB showed that xBTEB immunoreactivity is
excluded from proliferative cells in the tadpole brain
(Fig. 8, compare panels D [xBTEB immunoreactivity],
E [BrdU immunoreactivity] and F [merge]).
Discussion
Thyroid hormone induces dramatic morphological
and biochemical changes during amphibian meta-
morphosis, and these tissue transformations depend
on changes in gene expression. A central challenge
to understanding the mechanistic basis for this pro-
cess is to establish the identities and functions of
genes that are induced or repressed in the trans-
forming tissues. Towards this goal, we analyzed the
biochemical characteristics, functional properties,
and expression patterns of the T3-inducible gene
BTEB in X. laevis. We found that xBTEB binds DNA
with high affinity and can function as a transcriptional
activator on GC box-containing promoters. xBTEB
gene expression is developmentally and hormonally
regulated, and xBTEB protein parallels changes in its
mRNA. We hypothesize that BTEB participates in the
Fig. 7. Xenopus basic transcrip-
tion element binding protein
(xBTEB) mRNA expression is in-
duced by 3,5,3-triiodothyronine
(T3) in premetamorphic tadpole
brain. Nieuwkoop and Faber stage
52 tadpoles were treated with or
without 50 nM T3 for 48 h before
they were killed. Saggital sections
(10 µm) were hybridized with anti-
sense digoxigenin-labeled cDNA
probes for xBTEB (optic tectum,
xBTEB mRNA is green in panels A
and B [bar, 100 µm]; lateral motor
column, xBTEB mRNA is red in
panels C and D [bar, 50 µm]);
hybridization with sense probe
showed no staining (data not
shown). xBTEB mRNA and thyroid
hormone receptor (TR) protein are
expressed in the same cells. Dual
histochemistry for xBTEB mRNA
(red) and TR protein (green; ana-
lyzed by immunohistochemistry)
was conducted (the lateral motor
column is shown in panels C and
D). Note the low level of xBTEB
mRNA expression (cytoplasmic
red staining) and the absence of
detectable TR protein (lack of
nuclear staining) at this develop-
mental stage. Hormone treatment
was as described above (C,
untreated; D, 50 nM T3).
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autoinduction of TR gene expression during meta-
morphosis, and we found that TR protein and xBTEB
mRNA are upregulated in the same cells in the central
nervous system. xBTEB immunoreactivity was not
found in proliferating cells in the tadpole brain,
supporting the hypothesis that this protein does not
play a role in thyroid hormone-induced proliferation,
but may function in neural cell differentiation.
Xenopus laevis BTEB possesses similar DNA-
binding characteristics to rat BTEB1 (Sogawa et al.
1993b). In transient transfection assays, we found that
xBTEB activated transcription from the SV40 promoter,
which contains six GC boxes in tandem (pSVCAT;
Imataka et al. 1992). We also found that xBTEB
activated transcription from a promoter containing a
single GC box (pSV/MC53). Thus, while we cannot
rule out the possibility that xBTEB can function as a
transcriptional repressor on native promoters, our data
support the hypothesis that xBTEB functions as a
transcriptional activator.
Our findings with the pSVCAT plasmid, which con-
tains six GC boxes, is consistent with the findings of
Imataka et al. (1992). However, we did not find that
BTEB (frog or rat) repressed transcription on a pro-
moter possessing a single GC box (pSV/MC53), as
reported by Imataka et al. (1992). Instead, we found
that both proteins activated transcription from this
promoter. Although we attempted to carefully replicate
the experimental design of Imataka and colleagues
(i.e. using CV-1 cells, identical plasmids and DNA
concentrations, same transfection method) we cannot
rule out the possibility that there were slight differ-
ences in our protocol, or the way that our CV-1 cells
behaved, that might be responsible for the different
results. However, it is noteworthy that we found that
both rat and frog BTEB activated transcription from
this single GC box-containing promoter.
Previous studies showed that the X. laevis TR gene
is autoinduced by T3 during metamorphosis (Tata
et al. 1993) and in XTC-2 cells (Machuca & Tata 1992),
and a thyroid hormone response element was identi-
fied in its promoter (Machuca et al. 1995). Further-
more, the X. laevis TR promoter described by
Machuca et al. (1995) contains seven GC boxes that
could serve as binding sites for xBTEB or other
Krüppel or Sp family members. Notably, the
Fig. 8. Xenopus basic tran-
scription element binding
protein (xBTEB) in the tadpole
brain is developmentally and
hormonally regulated and is not
expressed in proliferating cells.
Double labeling immunohisto-
chemistry was used to analyze
xBTEB protein and bromode-
oxyuridine (BrdU)-labeled cells.
Premetamorphic tadpoles (Nie-
uwkoop and Faber [NF] stage
52; panels A–F) were reared
without (A–C) or with (D–F)
50 nM T3 for 48 h. BrdU was
added to the aquarium water to
a final concentration of 500 µM
3 h before tadpoles were killed,
to label mitotic cells. Saggital
sections (10 µm) were analyzed
by double labeling immuno-
histochemistry for xBTEB (red)
and BrdU (green; the optic
tectum and cerebellum are
shown). Note that xBTEB protein
is not expressed in prolifer-
ating cells identified by BrdU
labeling. Late prometamorphic/
early climax stage tadpoles
(NF stage 60) were reared in the
(G) absence or (H) presence of
50 nM T3 for 48 h before they
were killed. The panels show
xBTEB immunoreactivity in the
optic tectum. Bars, 100 µm.
378 E. D. Hoopfer et al.
expression of TR and xBTEB mRNAs have similar
expression patterns in tadpole tissues (compare
Yaoita & Brown 1990 and this study). We also demon-
strated by histochemistry that xBTEB and TR are
coordinately upregulated in the same brain cells.
These observations led us to hypothesize that the
coordinate upregulation of TR and xBTEB is func-
tionally related; that is, TR, in the presence of its
ligand, regulates xBTEB expression and, sub-
sequently, xBTEB influences TR expression. We
further hypothesize that the upregulation of TR
gene expression by T3 (autoinduction) is dependent
upon, or at least enhanced by, the coordinate
upregulation of xBTEB.
To begin to test this hypothesis, we overexpressed
the DBD of xBTEB in XTC-2 cells and found that it
competed for endogenous GC box-binding activity
and reduced both basal and T3-induced TR
promoter activity. These findings suggest that GC
box-binding proteins play a role in regulating
transcription of the frog TR gene, and could be
important for the autoinduction of TR during meta-
morphosis. GC box sequences in the human TR1
promoter were shown to be necessary for transcrip-
tional activity (Suzuki et al. 1995). Furthermore, pro-
teins present in fetal rodent brain that bind to these
sequences were not supershifted by antibodies to
Sp1–4 or Egr 1 or 2, suggesting that other GC box-
binding factors present in the developing brain regu-
late this promoter (Nagasawa et al. 1997). In this
regard, we have shown that BTEB1 is strongly upregu-
lated in a thyroid-dependent manner in the neonatal
rat brain (Denver et al. 1999).
Comparison of the postembryonic developmental
expression of xBTEB mRNA in three tissues (brain,
intestine and tail) showed that this gene is develop-
mentally regulated, similar to other metamorphosis-
associated genes (Shi 2000). The stage of maximal
expression in the three tissues differs, and parallels
the period of most active biochemical and morpho-
logical transformation in that tissue (Shi 2000). The
correlation of xBTEB expression with active tissue
remodeling/regression suggests that xBTEB could
play an active role in mediating T3 action during
metamorphosis.
Addition of T3 to the rearing water of premeta-
morphic tadpoles resulted in the precocious upregu-
lation of xBTEB mRNA in each of the three tissues
examined. Elevated xBTEB mRNA expression was
observed by 4–8 h following addition of the hormone
to the water, which is consistent with a previous report
from our laboratory in which xBTEB mRNA levels in the
brain were analyzed (Denver et al. 1997). Previous
work has supported the view that xBTEB is a direct T3
response gene (Wang & Brown 1993; Brown et al.
1996; Denver et al. 1997; see also Denver et al. 1999
for evidence for direct T3 regulation of the rat BTEB1
gene.) Furlow & Brown (1999) reported that one of the
frog BTEB genes (not specified) possesses a func-
tional TRE in its promoter. Expression of xBTEB mRNA
remained elevated throughout the 72 h that T3 was
present in the rearing water. A dose of 5 nM T3 was
sufficient to upregulate xBTEB mRNA expression in
the brain and intestine. However, we were unable to
detect a change in xBTEB mRNA expression in the tail
following addition of either 5 or 50 nM T3 (data not
shown). By contrast, the addition of 200 nM T3 caused
a strong increase in xBTEB mRNA accumulation in the
tail. This finding is consistent with previous findings
that the tail is less sensitive to T3 than other tadpole
tissues (i.e. brain, liver, hindlimb, intestine), and thus
this tissue does not show metamorphic changes until
late in metamorphic climax when T3 production is
maximal (Shi 2000).
In addition to the induction of xBTEB mRNA by the
addition of exogenous T3, we showed that the upregu-
lation of xBTEB during prometamorphosis depends on
endogenous T3. We also found that thyroid hormone
could upregulate xBTEB mRNA in the adult frog
brain. However, while plasma T4 concentrations were
increased 10-fold more than controls in the T4-treated
group, xBTEB mRNA expression increased only
30%. Nevertheless, our findings demonstrate thyroid
hormone regulation of a metamorphic gene in adult
amphibians, and suggest that the decline in the
expression of metamorphic genes following meta-
morphic climax is related to the decline in thyroid
hormone production, and not due to an irreversible
change in the ability of thyroid hormone to regulate
these genes. This contrasts with thyroid hormone-
regulated brain genes, including BTEB1, in rats,
whose continued expression becomes independent
of the thyroid after postnatal day 30 (Oppenheimer &
Schwartz 1997; Denver et al. 1999).
Previous work of ours has provided evidence for a
role of BTEB in neuronal process development
(Denver et al. 1999; Cayrou et al. 2002). For example,
overexpression of BTEB in N-2a cells causes a
dramatic increase in the number and length of
neurites, and this effect is dose-dependent (Denver
et al. 1999). Also, knockdown of BTEB in embryonic
rat neurons with antisense oligonucleotides blocks T3
effects on neurite branching in vitro (Cayrou et al.
2002). For these reasons we focused on the tadpole
brain for a detailed analysis of xBTEB mRNA and
protein. We showed that xBTEB mRNA is virtually
undetectable in premetamorphic tadpole brain
(analyzed by ISHH), but T3 produced a strong
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increase in expression throughout the brain, with
highest expression in the telencephalon, optic
tectum, hypothalamus, cerebellum and spinal cord. In
the optic tectum, the expression of xBTEB mRNA was
strongest in the subependymal and deep cellular
layers, with less expression in the periventricular
zones where proliferative responses to T3 are
observed (L. Huang and R. J. Denver, unpubl. data,
2001).
Immunohistochemistry using specific, affinity-sub-
tracted anti-xBTEB IgG demonstrated nuclear xBTEB
immunoreactivity in the same brain regions as those
identified by ISHH. Highest levels of xBTEB immuno-
reactivity were observed in the hypothalamus and the
lateral motor column, two brain regions previously
reported to be most sensitive to T3 action, and regions
that undergo demonstrable morphological and bio-
chemical changes during metamorphosis (Denver
1996). Similar to the effects of T3 on xBTEB mRNA
expression, T3 dramatically increased xBTEB immuno-
reactivity in the premetamorphic tadpole brain.
Comparison of xBTEB immunoreactivity in the optic
tectum of premetamorphic and late prometamorphic
tadpoles showed a significantly higher level of expres-
sion during spontaneous metamorphosis. We con-
clude that changes in xBTEB mRNA largely parallel
changes in xBTEB protein.
In double labeling experiments for BrdU and xBTEB
protein, and using confocal microscopy, we found that
xBTEB immunoreactivity is excluded from proliferating
cells in the tadpole brain. xBTEB immunoreactivity
was found predominantly in cell layers just distal to the
proliferative zone which undergo differentiation and
migration. Berry et al. (1998) reported that xBTEB
mRNA was expressed in proliferating cells in the
tadpole brain. However, they did not show their data
for xBTEB in the brain, nor did they use confocal
microscopy to verify co-localization of BTEB and
BrdU. We hypothesize that BTEB is upregulated in
cells undergoing differentiation and plays a role in the
upregulation of proteins necessary for the expression
of the adult neuronal phenotype. In addition to the
present expression results, support for this hypothesis
comes from our previous findings showing that over-
expression of BTEB causes neurite outgrowth, and
antisense treatment reduces neurite branching
induced by T3 in neural cells (Denver et al. 1999;
Cayrou et al. 2002). A primary effect of T3 on the
developing brain is on neuronal process develop-
ment. Thyroid hormone has been shown to be
essential to the proper maturation of dendritic spines
and axons, and synaptic junctions in the developing
brain. Our findings support the view that BTEB,
through its positive action on the transcription of
essential genes, is a critical intermediate in the action
of T3 on the developing brain.
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